CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,468,126 | +2797.7% | 1,037,433 | +2028.1% | 0.02% | +1700.0% |
Q2 2023 | $533,813 | +507.5% | 48,750 | +383.8% | 0.00% | – |
Q1 2023 | $87,871 | -43.3% | 10,077 | -76.3% | 0.00% | – |
Q3 2021 | $155,000 | -16.2% | 42,448 | 0.0% | 0.00% | – |
Q2 2021 | $185,000 | -42.2% | 42,448 | -39.7% | 0.00% | – |
Q1 2021 | $320,000 | -23.8% | 70,442 | -3.8% | 0.00% | – |
Q4 2020 | $420,000 | +14.8% | 73,215 | +44.8% | 0.00% | – |
Q3 2020 | $366,000 | +44.1% | 50,554 | -30.6% | 0.00% | – |
Q2 2020 | $254,000 | +17.6% | 72,812 | -50.0% | 0.00% | – |
Q1 2020 | $216,000 | +43.0% | 145,624 | +89.2% | 0.00% | – |
Q4 2019 | $151,000 | -61.7% | 76,978 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $394,000 | +4277.8% | 76,978 | +5923.3% | 0.00% | – |
Q2 2019 | $9,000 | -47.1% | 1,278 | 0.0% | 0.00% | – |
Q1 2019 | $17,000 | +70.0% | 1,278 | 0.0% | 0.00% | – |
Q4 2018 | $10,000 | -41.2% | 1,278 | -16.0% | 0.00% | – |
Q3 2018 | $17,000 | -5.6% | 1,522 | +15.1% | 0.00% | – |
Q2 2018 | $18,000 | – | 1,322 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |